| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 637126 | Null | 0.0414190425892865 | 0.22132027 |
| NSC 637729 | Naphthalene-1,2-dione, 1,2-dihydro-4-[(3-pyridinyl)amino]- | 0.0414190425892865 | 0.14142833 |
| NSC 639518 | Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride | 0.0414190425892865 | 0.53911146 |
| NSC 641319 | 5,12-Naphthacenedione, 10-[[3-[[5,5-di(acetyloxy)pentyl]amino]- 2,3,6-trideoxy-.alpha.-L-lyxohexopyranosyl]oxy]- 7,8,9,10-tetrahydro-6,8,11-trihydroxy- 8-(hydroxyacetyl)-1-methoxy-, hydrochloride | 0.0414190425892865 | 0.44575 |
| NSC 655901 | ANTINEOPLASTIC-655901 | 0.0414190425892865 | 0.48736001 |
| NSC 660032 | Null | 0.0414190425892865 | -0.085163436 |
| NSC 661941 | 2-(3-chloropropyloxy)naphthazarin | 0.0414190425892865 | 0.31294905 |
| NSC 670226 | trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid | 0.0414190425892865 | 0.55179067 |
| NSC 673141 | Null | 0.0414190425892865 | 0.45945649 |
| NSC 673181 | Null | 0.0414190425892865 | 0.23790126 |